Literature DB >> 1651449

Inclusion body myositis with cricopharyngeus muscle involvement and severe dysphagia.

A Verma1, W G Bradley, A M Adesina, R Sofferman, W W Pendlebury.   

Abstract

A patient with inclusion body myositis (IBM) is presented. Unusual aspects of this case include a myopathy of 36 years duration, severe dysphagia due to cricopharyngeus muscle dysfunction, improvement with cricopharyngeus myotomy, and a diagnostic cricopharyngeus muscle biopsy.

Entities:  

Mesh：

Year:  1991        PMID： 1651449     DOI： 10.1002/mus.880140514

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


  12 in total

1.  Inclusion Body Myositis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-01       Impact factor: 3.598

2.  Therapeutic advances and future prospects in immune-mediated inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

Review 3.  Immunotherapy of myositis: issues, concerns and future prospects.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Rheumatol       Date:  2010-02-02       Impact factor: 20.543

4.  Inflammatory myopathies.

Authors:  B Jane Distad; Anthony A Amato; Michael D Weiss
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.598

Review 5.  Update on treatment of inclusion body myositis.

Authors:  Maren Breithaupt; Jens Schmidt
Journal:  Curr Rheumatol Rep       Date:  2013-05       Impact factor: 4.592

Review 6.  The benefits and limitations of a physical training program in patients with inflammatory myositis.

Authors:  M Lawson Mahowald
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

7.  Inclusion body myositis with abundant ring fibers.

Authors:  M R Del Bigio; V Jay
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Cricopharyngeal bar on videofluoroscopy: high specificity for inclusion body myositis.

Authors:  Kenichiro Taira; Toshiyuki Yamamoto; Madoka Mori-Yoshimura; Kazuaki Sajima; Hotake Takizawa; Jun Shinmi; Yasushi Oya; Ichizo Nishino; Yuji Takahashi
Journal:  J Neurol       Date:  2020-09-26       Impact factor: 4.849

9.  Inclusion body myositis: clinical and histopathological features of 36 patients.

Authors:  S Beyenburg; S Zierz; F Jerusalem
Journal:  Clin Investig       Date:  1993-05

Review 10.  Autoimmune Myopathies: Updates on Evaluation and Treatment.

Authors:  Emer R McGrath; Christopher T Doughty; Anthony A Amato
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.